.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,423,169

« Back to Dashboard

Details for Patent: 7,423,169

Title:Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
Abstract: The synthesis of 1-(acyloxy)-alkyl carbamates of GABA analogs from 1-haloalkyl carbamates of GABA analogs are described. Also described are new 1-haloalkyl carbamates of GABA analogs.
Inventor(s): Raillard; Stephen P. (Mountain View, CA), Zhou; Cindy X. (Palo Alto, CA), Yao; Fenmei (Mountain View, CA), Manthati; Suresh Kumar (Cupertino, CA), Xiang; Jia-Ning (Palo Alto, CA), Gallop; Mark A. (Los Altos, CA)
Assignee: Xenoport, Inc. (Santa Clara, CA)
Filing Date:Aug 21, 2006
Application Number:11/511,901
Claims:1. A compound of Formula (II) ##STR00019## wherein: X is F, Cl, Br or I; n is 0 or 1; R.sup.2 and R.sup.3 are independently hydrogen, alkyl, substituted alkyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, carbamoyl, substituted carbamoyl, cycloalkyl, substituted cycloalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl, or optionally, R.sup.2 and R.sup.3 together with the atom to which they are bonded form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring; R.sup.4 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl; R.sup.5 is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, carbamoyl, substituted carbamoyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl, or optionally, R.sup.4 and R.sup.5 together with the atoms to which they are attached form a cycloheteroalkyl or substituted cycloheteroalkyl ring; R.sup.6 and R.sup.9 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl and substituted heteroarylalkyl; R.sup.7 and R.sup.8 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, acyl, substituted acyl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroarylalkyl and substituted heteroarylalkyl, or optionally, R.sup.7 and R.sup.8 together with the carbon atom to which they are attached form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl or bridged cycloalkyl ring; and R.sup.10 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, aryldialkylsilyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl or trialkylsilyl.

2. The compound of claim 1 derived from a GABA analog of Formula (IV): ##STR00020## wherein the GABA analog of Formula (IV) is selected from the group consisting of: 1-Aminomethyl-1-cyclohexane acetic acid (i.e. gabapentin); 1-Aminomethyl-1-(3-methylcyclohexane) acetic acid; 1-Aminomethyl-1-(4-methylcyclohexane) acetic acid; 1-Aminomethyl-1-(4-isopropylcyclohexane) acetic acid; 1-Aminomethyl-1-(4-tert-butylcyclohexane) acetic acid; 1-Aminomethyl-1-(3,3-dimethylcyclohexane) acetic acid; 1-Aminomethyl-1-(3,3,5,5-tetramethylcyclohexane) acetic acid; 1-Aminomethyl-1-cyclopentane acetic acid; 1-Aminomethyl-1-(3-methylcyclopentane) acetic acid; 1-Aminomethyl-1-(3,4-dimethylcyclopentane) acetic acid; 7-Aminomethyl-bicyclo[2.2.1]hept-7-yl acetic acid; 9-Aminomethyl-bicyclo[3.3.1]non-9-yl acetic acid; 4-Aminomethyl-4-(tetrahydropyran-4-yl) acetic acid; 3-Aminomethyl-3-(tetrahydropyran-3-yl) acetic acid; 4-Aminomethyl-4-(tetrahydrothiopyran-4-yl) acetic acid; 3-Aminomethyl-3-(tetrahydrothiopyran-3-yl) acetic acid; (S)-3-Aminomethyl-5-methyl-hexanoic acid (i.e., pregabalin); 3-Aminomethyl-5-methyl-heptanoic acid; 3-Aminomethyl-5-methyl-octanoic acid; 3-Aminomethyl-5-methyl-nonanoic acid; 3-Aminomethyl-5-methyl-decanoic acid; 3-Aminomethyl-5-cyclopropyl-hexanoic acid; 3-Aminomethyl-5-cyclobutyl-hexanoic acid; 3-Aminomethyl-5-cyclopentyl-hexanoic acid; 3-Aminomethyl-5-cyclohexyl-hexanoic acid; 3-Aminomethyl-5-phenyl-hexanoic acid; 3-Aminomethyl-5-phenyl-pentanoic acid; 3-Aminomethyl-4-cyclobutyl-butyric acid; 3-Aminomethyl-4-cyclopentyl-butyric acid; 3-Aminomethyl-4-cyclohexyl-butyric acid; 3-Aminomethyl-4-phenoxy-butyric acid; 3-Aminomethyl-5-phenoxy-hexanoic acid; and 3-Aminomethyl-5-benzylsulfanyl-pentanoic acid.

3. The compound of claim 1, wherein the compound of Formula (II) is a compound of Formulae (VII) or (VIII): ##STR00021## and n is 0.

4. The compound of claim 3, wherein X is chloro, bromo or iodo, R.sup.10 is hydrogen, allyl, benzyl or trimethylsilyl, R.sup.2 is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclohexyl or phenyl and R.sup.3 is hydrogen.

5. The compound of claim 3, wherein X is chloro, bromo or iodo, R.sup.10 is hydrogen, allyl, benzyl or trimethylsilyl, R.sup.2 is methyl and R.sup.3 is methyl.

6. The compound of claim 5, wherein X is chloro, bromo or iodo, R.sup.10 is hydrogen, allyl, benzyl or trimethylsilyl, R.sup.2 is methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl or cyclohexyloxycarbonyl and R.sup.3 is methyl.

7. The compound of claim 3, wherein X is chloro, bromo or iodo, R.sup.1 is hydrogen, allyl, benzyl or trimethylsilyl, and R.sup.2 and R.sup.3 together with the atom to which they are attached form a cyclohexyl ring.

8. The compound of claim 3, wherein X is chloro, R.sup.10 is hydrogen, allyl, benzyl or trimethylsilyl, R.sup.2 is hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl and R.sup.3 is hydrogen.

9. The compound of claim 3, wherein X is chloro, R.sup.10 is hydrogen, allyl, benzyl or trimethylsilyl, R.sup.2 is methyl, n-propyl or isopropyl, and R.sup.3 is hydrogen.

10. The compound of claim 3, wherein X is chloro, R.sup.10 is hydrogen, R.sup.2 is methyl, and R.sup.3 is hydrogen.

11. The compound of claim 3, wherein X is chloro, R.sup.10 is allyl, R.sup.2 is methyl, and R.sup.3 is hydrogen.

12. The compound of claim 3, wherein X is chloro, R.sup.10 is benzyl, R.sup.2 is methyl, and R.sup.3 is hydrogen.

13. The compound of claim 3, wherein X is chloro, R.sup.10 is trimethylsilyl, R.sup.2 is methyl, and R.sup.3 is hydrogen.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc